Searched for
PHARMA BIGGIES
Biosimilar brand buy to help Intas Pharma take on biggiesIn one of the biggest deals worldwide for a biosimilar brand, Ahmedabad-based Intas agreed to buy Udenyca-the brand name for medication peg...- Sun Pharmaceuticals stock: Why analysts are bullish on this share nowMargin improvement, better sales from Indian and the US operations, reasonable valuation and a possible rerating in the near future are the...
- Not biggies, go for these niche pharma cos: Dipan MehtaBuy contract manufacturing pharma companies on correction, says Mehta.
- Government’s drug price caps may trigger showdown with USUS pharma biggies are at the receiving end of the Donald Trump administration’s ire due to rising drug prices in that country, and this may...
- Indian pharma cos get record 300 USFDA generic drug nodsThe final approvals for Indian players are up by nearly 43% from 211 in 2016, and corner about 40% of all global filings in the highly lucr...
- Aurobindo shares leap with FDA approval for key drugMarkets were anticipating the approval for Sevelamer as it is one of the complex generic drug.
- Here is why a major correction is unlikely in the market nowNearly half of the stocks are trading at 10% lower than their one-year highs on BSE200.
- IT, pharma counters at rational valuations but the worst may not be over yetSustained bad performances of IT biggies have triggered obituaries of the once sunshine sector. US FDA has changed the way pharma sector is...
- TCS, Infosys in Forbes India 'Super 50' list; Tata Motors, HUL droppedThe list, in its second year, also features 14 newcomers, including Infosys, Maruti Suzuki, Bharat Forge, Alembic Pharma, Gillette India, H...
- Club Nifty’s net to drop despite growth in salesThe lack-lustre performance will also affect the overall operating margin, which is expected to drop by 440 basis points to an eight quarte...
- ITC, Britannia top picks in FMCG sector: Ajay BodkeWe would continue to advocate ITC and Britannia as the top picks in the FMCG sector.
- Companies to gain as Big Pharma goes genericFaced with losses once its blockbusters start losing patents, Big Pharma is now devising strategies to counter the impact.
- Pharma biggies disclose payments made to doctorsPharma biggies worldwide have started disclosing payments made to physicians, including dollars spent on consulting gigs, clinical trials a...
- India is now a player in M&A premier leagueIt will be the third largest deal so far in 2009 and if pharma is excluded, it will be the largest deal so far globally.
- Obama's tax worries pharma tooApart from IT, the domestic pharma industry is also worried over President Obama's proposal to end tax breaks for US companies, which are e...
- Indian generic companies may tread Ranbaxy pathRanbaxy's patent settlement with Pfizer may lead more Indian generic cos to go for out-of-court settlements with their innovator counterpar...
- Drug price control to hurt investments in India: MNCsThe Centre recently announced its intention to bring all 354 medicines on the National Lists of Essential Medicines under price control.
- Now, BPOs moves towards researchAfter BPOs & KPOs, outsourcing segments are all set to move towards Research Process Outsourcing (RPO).
- Centre plans excise rejig for job work, textile, pharma to take hitThe Finance Ministry has zeroed in on a policy measure that could impact the bottomlines of textile and pharma biggies, but bolster the gov...
- Idma seeks automatic licence systemTHE Indian Drug Manufacturers' Association, in order to reap the full benefits of the Doha Agreement related to health and pharma, has dema...
Load More
